Cell wall fraction of Mycobacterium indicus pranii shows potential Th1 adjuvant activity.
Saqib M, Khatri R, Singh B, Gupta A, Bhaskar S. International immunopharmacology. 2019; 70408-416.
Optimization of secretion and surface localization of heterologous OVA protein in mycobacteria by using LipY as a carrier.
Burggraaf MJ, Ates LS, Speer A, van der Kuij K, Kuijl C, Bitter W. Microbial cell factories. 2019; 18(1):44.
National leprosy symposium 2018
Community skin health. 2019; 15(1):
International Textbook of Leprosy.
Scollard DM, Gillis TP. American Leprosy Missions; 2019.
BCG vaccine and leprosy household contacts: Protective effect and probability to becoming sick during follow-up.
Gomes R, Antunes D, Dos Santos D, Sabino E, Oliveira D, Goulart I. Vaccine. 2019;
The effect of contact history and immunization status on the case of leprosy
Nurzila U, Adriyani R. Jurnal Berkala Epidemiologi. 2019; 7(2):
The Global Fight to Develop Antipoverty Vaccines in the Antivax Era.
Hotez PJ. Human vaccines & immunotherapeutics. 2018;
Mycobacterium indicus pranii protein MIP_05962 induces Th1 cell mediated immune response in mice.
Sharma A, Saqib M, Sheikh JA, Ehtesham NZ, Bhaskar S, Chaudhuri TK, et al.. International journal of medical microbiology : IJMM. 2018;
Potential of adjunctive Mycobacterium w (MIP) immunotherapy in reducing the duration of standard chemotherapy against tuberculosis.
Chahar M, Rawat K, Reddy PV, Gupta U, Natrajan M, Chauhan D, et al.. The Indian journal of tuberculosis. 2018; 65(4):335-344.
BCG vaccines: WHO position paper – February 2018.
Releve epidemiologique hebdomadaire. 2018; 93(8):73-96.
Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.